Related Experiment Videos

[Acute intestinal amebiasis treated with aminosidine]

Insights

Aminosidine sulfate effectively treats acute diarrheal syndrome in children caused by histolytic ameba. This clinical study evaluates aminosidine

Area of Science:

  • Pediatric infectious diseases
  • Gastroenterology
  • Clinical pharmacology

Background:

  • Acute diarrheal syndrome is a common pediatric illness.
  • Histolytic ameba remains a significant etiological agent in gastroenteritis.
  • Aminosidine sulfate is an antibiotic with potential antiprotozoal activity.

Purpose of the Study:

  • To evaluate the therapeutic efficacy of aminosidine sulfate in children with acute diarrheal syndrome.
  • To assess the role of histolytic ameba in pediatric gastroenteritis.
  • To determine the clinical-therapeutic action of aminosidine sulfate.

Main Methods:

  • A clinical-therapeutic assay was conducted.
  • The study involved children admitted to a pediatric teaching hospital.
  • Patients were treated with aminosidine sulfate.

Main Results:

  • The study presents findings on the clinical-therapeutic assay.
  • Aminosidine sulfate was administered to children with acute diarrheal syndrome.
  • The therapeutic action of aminosidine was evaluated in this cohort.

Conclusions:

  • Histolytic ameba is a relevant cause of gastroenteritis in children.
  • Aminosidine sulfate demonstrated therapeutic action in the evaluated cases.
  • Further evaluation of aminosidine sulfate for amebic gastroenteritis is warranted.

Related Concept Videos